Overview

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 18F-Al labeled RGD is safety and effective for cancer diagnosis and therapy response.
Phase:
Phase 1
Details
Lead Sponsor:
Wuxi No. 4 People's Hospital